Schwaiger, JP;
Loder, CD;
Dobarro, D;
Kaier, T;
Reddecliffe, S;
Schreiber, BE;
Handler, C;
... Coghlan, JG; + view all
(2017)
Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis.
Scientific Reports
, 7
, Article 43304. 10.1038/srep43304.
![[thumbnail of Published article]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) |
Text (Published article)
reprint Schwaiger_et_al-2017-Scientific_Reports.pdf - Published Version Download (1MB) |
Preview |
Text (Supplementary information)
Schwaiger_Optical_coherence_tomography_Suppl.pdf Download (201kB) | Preview |
Abstract
Our current understanding of the pathophysiology of pulmonary vascular disease is incomplete, since information about alterations of the pulmonary vasculature in pulmonary arterial hypertension (PAH) is primarily provided by autopsy or tissue specimens. The aim of this study was to compare the distal pulmonary vasculature of <2 mm in diameter in Systemic Sclerosis (SSc) patients with (n = 17) and without (n = 5) associated PAH using Optical Coherence Tomography during Right Heart catheterization. SSc-PAH patients showed significant thickening of Intima Media Thickening Area compared to patients without PAH (27 +/- 5.8% vs. 21 +/- 1.4%, p = 0.024). A good haemodynamic response to previous targeted PAH treatment was associated with a significantly greater number of small pulmonary artery side branches <300 μm per cm vessel (3.8 +/- 1.1 vs. 1.8 +/- 1.1; p = 0.010) and not associated with Intima Media thickening Area (26 +/- 5.4% vs. 28 +/- 6.7%; p = 0.6). Unexpected evidence of pulmonary artery thrombus formation was found in 19% of SSc-PAH patients. This is the first in-vivo study demonstrating a direct link between a structural abnormality of pulmonary arteries and a response to targeted treatment in PAH. Intravascular imaging may identify subgroups that may benefit from anticoagulation.
| Type: | Article |
|---|---|
| Title: | Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/srep43304 |
| Publisher version: | http://dx.doi.org/10.1038/srep43304 |
| Language: | English |
| Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| Keywords: | Interventional cardiology; Systemic sclerosis; Thrombosis |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1544974 |
Archive Staff Only
 |
View Item |
